4//SEC Filing
Novak Rodger 4
Accession 0001209191-21-044012
CIK 0001674416other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 5:33 PM ET
Size
4.7 KB
Accession
0001209191-21-044012
Insider Transaction Report
Form 4
Novak Rodger
DirectorChief Executive Officer
Transactions
- Sale
Common Shares
2021-06-28$156.55/sh−25,000$3,913,750→ 598,007 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001682017
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 5:33 PM ET
- Size
- 4.7 KB